Vaccines (Dec 2022)

SARS-CoV-2 in Namibian Dogs

  • Umberto Molini,
  • Lauren M. Coetzee,
  • Tanya Engelbrecht,
  • Lourens de Villiers,
  • Mari de Villiers,
  • Iolanda Mangone,
  • Valentina Curini,
  • Siegfried Khaiseb,
  • Massimo Ancora,
  • Cesare Cammà,
  • Alessio Lorusso,
  • Giovanni Franzo

DOI
https://doi.org/10.3390/vaccines10122134
Journal volume & issue
Vol. 10, no. 12
p. 2134

Abstract

Read online

The pandemic of coronavirus disease 19 (COVID-19) has focused the attention of researchers, and especially public opinion, on the role of the human-animal-environment interface in disease emergence. At the beginning of the COVID-19 pandemic, media reports regarding the role of pets in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused significant concern and social anxiety. Although nowadays proven negligible in developed countries, essentially no studies have been performed in low-income African areas where companion animals are often raised differently from high income countries, and the contact patterns occurring in these scenarios could affect the epidemiological scenario. An extensive molecular biology survey was performed from March 2022 to September 2022 on Namibian dogs residing in urban and rural areas, showing a low but not negligible SARS-CoV-2 prevalence (1%; 95CI: 0.33–2.32%) of 5 out of 500. In only one instance (i.e., a 4-year-old female Labrador) was there a clear association that could be established between the infections of the owner and animal. In all other cases, no evidence of human infection could be obtained and no episodes of COVID-19 were reported by the owners. Although no consistent evidence of pet-to-pet transmission was proven in the present study, a cautionary principle suggests intensive and dedicated investigation into companion animal populations, especially when animal contact is frequent and a particularly susceptible population is present.

Keywords